中文 | English
Return
Total: 3076 , 1/308
Show Home Prev Next End page: GO
Author:( rong, XU)

1.Comparison of Legal Liability between US FDCA and Drug Administration Law of PRC

Rong XU ; Rong SHAO

China Pharmacy 1991;0(03):-

2.Enlightenment of American Drug Recall System on Drug Safety in China

Rong XU ; Rong SHAO

China Pharmacy 1991;0(06):-

3.The role of serum creatinine or Cystatin C in chronic kidney disease staging and prognosis assessment

Rong XU

Chinese Journal of Laboratory Medicine 2014;(6):415-419

4.Potency Determination of Lonicera Granule Based on Bacterial Inhibitory Activity

Rong XU

China Pharmacist 2016;19(2):369-371

5.Simultaneous Determination of 7 Flavonoids in Fengliaochangweikang Capsules and Optimization of Ex-traction Process for Total Flavones

Rong XU

China Pharmacist 2017;20(2):259-262

7.Applications of Nanomedicine in Breast Cancer Therapy

Chenghan MEI ; Rong XU

Herald of Medicine 2015;(10):1267-1271

8.The feasibility studies of using acute normovolemic hemodilution in the elderly patients undergoing knee arthroplasty

Rong MO ; Jieming XU

Chinese Journal of Primary Medicine and Pharmacy 2006;0(06):-

9.Economic Analysis on Effects of TRIPS on the Conflict between Drug Patent Protection and Public Health

Jun XU ; Rong SHAO

China Pharmacy 2007;0(31):-

10.Determination of acid phosphatase activity in macrophages

Qinhui XU ; Kangtai RONG

Chinese Journal of Immunology 1985;0(03):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3076 , 1/308 Show Home Prev Next End page: GO